GW Pharmaceuticals plc Reports 2014 Q4 and Full Year Financial Results

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Dec 02, 2014

-Conference Call Today at 8:00 a.m. ET, 1:00 p.m. GMT-

London, UK, 2 December 2014: GW Pharmaceuticals plc (NASDAQ: GWPH, AIM: GWP, GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces financial results for the fourth quarter and year ended 30 September 2014.

Recent News